首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: Germinated and Nongerminated Conidial Suspensions for Testing of Susceptibilities of Aspergillus spp. to Amphotericin B Itraconazole Posaconazole Ravuconazole and Voriconazole
【2h】

Note: Germinated and Nongerminated Conidial Suspensions for Testing of Susceptibilities of Aspergillus spp. to Amphotericin B Itraconazole Posaconazole Ravuconazole and Voriconazole

机译:注意:用于测试曲霉属菌种的发芽和未发芽的分生孢子悬浮液。两性霉素B伊曲康唑泊沙康唑拉伏康唑和伏立康唑

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effect of germinated and nongerminated conidia of Aspergillus spp. on the fungistatic (National Committee for Clinical Laboratory Standards document M38-P) and fungicidal activities (MICs and minimal fungicidal concentrations [MFCs] respectively) of amphotericin B, itraconazole, posaconazole (), ravuconazole (BMS-207147), and voriconazole was evaluated. MFCs were the lowest drug dilutions that showed fewer than three colonies (99.9% killing). Overall, the MICs (0.12 to 4 μg/ml) and MFCs (0.5 to >8 μg/ml) of all of the agents tested with both inocula were the same or within 2 dilutions for the 72 isolates. Therefore, MICs and MFCs can be obtained with convenient and standardized nongerminated conidia.
机译:曲霉菌的发芽和未发芽分生孢子的影响。对两性霉素B,伊曲康唑,泊沙康唑(),雷伏康唑(BMS-207147)和伏立康唑的杀菌性能(国家临床实验室标准委员会文件M38-P)和杀菌活性(分别为MIC和最小杀菌浓度[MFCs])进行评估。 MFCs是最低的药物稀释液,显示少于三个菌落(99.9%的杀死率)。总体而言,用这两种接种物测试的所有试剂的MIC(0.12至4μg/ ml)和MFC(0.5至> 8μg/ ml)都相同或在72种分离物中稀释2次。因此,可以通过方便且标准化的未发芽分生孢子获得MIC和MFC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号